Molecular targets of honey bee’s products in cancer prevention and treatment

Chemotherapy and radiotherapy are currently the main treatments for cancer but their toxicities on the surrounding normal cells limit their use in cancer therapy. Moreover, many cancers have developed some resistance to the available anticancer chemicals and put in failure the chemotherapy currently used in the cancer treatment. This failure of the targeted monotherapy resulting from bypass mechanisms has obligated researchers to use agents that interfere with multiple cell-signaling pathways. Recently, researches focused on the use of natural products which can target cancer promoting factors genes expression. Of these natural products, honey has been extensively studied. The pharmacological properties of honey include antioxidant, anti-inflammatory, antibacterial, immunomodulatory, estrogenic and anti-cancer effects. The honey bee’s products are potent sources of nutritional components including sugar, amino-acids, water and minerals. Furthermore honey contains chemopreventive compounds such as flavonoids, phenol acids, tannins, vitamins that may interfere with multiple cell’s pathways and hereby reduce the incidence of many types of cancers. However, the molecular mechanisms of honey bee’s products in cancer prevention and treatment are less known. This review highlights the molecular mechanism of honey bioactive compounds in cancer prevention and treatment.

[1]  Sumit Dadhwal,et al.  Honey reduces the metastatic characteristics of prostate cancer cell lines by promoting a loss of adhesion , 2018, PeerJ.

[2]  Xiuwen Zhu,et al.  Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells , 2018, Oncology letters.

[3]  M. El-Houseini,et al.  Protective Role of Magic Fruit and Honey Bee against Human Hepatocarcinogenesis , 2017 .

[4]  Agnes Aruna John,et al.  Honey and its Phytochemicals: Plausible Agents in Combating Colon Cancer through its Diversified Actions , 2016 .

[5]  M. Tuorkey.  Molecular targets of luteolin in cancer , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[6]  S. Nabavi,et al.  Molecular mechanisms underlying anticancer effects of myricetin. , 2015, Life sciences.

[7]  Goon Jo Aan,et al.  Mechanism of Chemoprevention against Colon Cancer Cells Using Combined Gelam Honey and Ginger Extract via mTOR and Wnt/β-catenin Pathways. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[8]  Jin Jiang,et al.  Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis , 2015, International journal of molecular sciences.

[9]  Y. M. Kim,et al.  Anti-angiogenic effects of resveratrol in combination with 5-fluorouracil on B16 murine melanoma cells. , 2015, Molecular medicine reports.

[10]  J. Baharara,et al.  Cytotoxic and Pro-Apoptotic Effects of Honey Bee Venom and Chrysin on Human Ovarian Cancer Cells , 2015 .

[11]  R. M. Zulkifli,et al.  Isolation and Identification of Potential Antineoplastic Bioactive Phenolic Compounds in Malaysian Honeys , 2015 .

[12]  A. Pawan,et al.  Anti-Cancer Strategies of Methylglyoxal A Review , 2015 .

[13]  Wenlin Huang,et al.  Antioxidative Dietary Compounds Modulate Gene Expression Associated with Apoptosis, DNA Repair, Inhibition of Cell Proliferation and Migration , 2014, International journal of molecular sciences.

[14]  F. Giampieri,et al.  The Composition and Biological Activity of Honey: A Focus on Manuka Honey , 2014, Foods.

[15]  M. Jaakkola,et al.  Phenolic Acid Composition, Antiatherogenic and Anticancer Potential of Honeys Derived from Various Regions in Greece , 2014, PloS one.

[16]  Ji-Youn Jung,et al.  Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells. , 2014, International journal of molecular medicine.

[17]  L. E. B. Soledade,et al.  Phenolic profile, antioxidant activity and palynological analysis of stingless bee honey from Amazonas, Northern Brazil. , 2013, Food chemistry.

[18]  G. Nicolini,et al.  Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis. , 2013, International journal of oncology.

[19]  Sonja Loges,et al.  Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. , 2013, The Journal of clinical investigation.

[20]  Ying-Jan Wang,et al.  Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors. , 2013, Carcinogenesis.

[21]  C. Jeong,et al.  Antiangiogenic Effects of P‐Coumaric Acid in Human Endothelial Cells , 2013, Phytotherapy research : PTR.

[22]  O. Erukainure,et al.  Acacia Honey Modulates Cell Cycle Progression, Pro-inflammatory Cytokines and Calcium Ions Secretion in PC-3 Cell Lines , 2012 .

[23]  Guang Liang,et al.  Anticancer molecules targeting fibroblast growth factor receptors. , 2012, Trends in pharmacological sciences.

[24]  Xueting Cai,et al.  The molecular mechanism of luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cells. , 2012, Oncology reports.

[25]  P. Rao,et al.  Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line‐specific apoptotic mechanisms , 2012, International journal of cancer.

[26]  J. T. Afshari,et al.  Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3 , 2011, Clinics.

[27]  N. Yaacob,et al.  Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[28]  F. Chou,et al.  Protocatechuic acid inhibits cancer cell metastasis involving the down‐regulation of Ras/Akt/NF‐κB pathway and MMP‐2 production by targeting RhoB activation , 2011, British journal of pharmacology.

[29]  R. S. Murugan,et al.  The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. , 2010, European journal of pharmacology.

[30]  M. A. Mohd,et al.  Ellagic acid, phenolic acids, and flavonoids in Malaysian honey extracts demonstrate in vitro anti-inflammatory activity. , 2010, Nutrition research.

[31]  S. Kuntz,et al.  Title: Chrysin Blocks Topotecan-induced Apoptosis in Caco-2 Cells in Spite of Inhibition of Abc-transporters Chrysin Blocks Topotecan-induced Apoptosis in Caco-2 Cells in Spite of Inhibition of Abc-transporters , 2022 .

[32]  H. Hara,et al.  Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells , 2009, BMC complementary and alternative medicine.

[33]  Hsi-Chin Wu,et al.  Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. , 2009, Journal of agricultural and food chemistry.

[34]  S. Jaganathan,et al.  Antiproliferative Effects of Honey and of Its Polyphenols: A Review , 2009, Journal of biomedicine & biotechnology.

[35]  J. Reynolds,et al.  The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down‐regulating the expression of heat shock protein 90 , 2008, The Prostate.

[36]  M. Viuda‐Martos,et al.  Functional properties of honey, propolis, and royal jelly. , 2008, Journal of food science.

[37]  A. von Deimling,et al.  The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin , 2008, Molecular Cancer Therapeutics.

[38]  E. A. Rogozin,et al.  Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. , 2008, Cancer research.

[39]  E. Sen,et al.  Kaempferol induces apoptosis in glioblastoma cells through oxidative stress , 2007, Molecular Cancer Therapeutics.

[40]  L. Andĕra,et al.  Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts , 2007, Molecular Cancer Therapeutics.

[41]  C. Ong,et al.  Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase–mediated p53 phosphorylation and stabilization , 2007, Molecular Cancer Therapeutics.

[42]  Shishir Shishodia,et al.  Molecular targets of dietary agents for prevention and therapy of cancer. , 2006, Biochemical pharmacology.

[43]  S. Shukla,et al.  Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft , 2006, Molecular Cancer Therapeutics.

[44]  Jen-kun Lin,et al.  Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase. , 2005, Biochemical pharmacology.

[45]  Jen-kun Lin,et al.  Apigenin Induces Apoptosis through Proteasomal Degradation of HER2/neu in HER2/neu-overexpressing Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 2004, Journal of Biological Chemistry.

[46]  H. Kuo,et al.  Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. , 2003, Biochemical pharmacology.

[47]  E. Schleicher,et al.  Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. , 2000, American journal of respiratory cell and molecular biology.